The U.S. pharmaceutical market is at a critical inflection point in early 2026. For decades, the industry has operated within a framework that, while fostering significant innovation, has also ...

High-value assets including domain controllers, web servers, and identity infrastructure are frequent targets in ...

New data from 2026 shows DAOs centralising, not decentralising. Corporate governance research explains why participation ...

A Foundation of Scientific Integrity: The CAS Pedigree The primary differentiator for Labor in a crowded global market is its “Research-First” DNA. Born from the Beijing Branch of the Chinese Academy ...

Threat actors abused trusted Trivy distribution channels to inject credential‑stealing malware into CI/CD pipelines worldwide ...

Ben Debney’s article ‘Platformism vs. Syndicalism’ addresses what he sees as a false dichotomy between distinct tendencies within the anarchist movement. He wants to assure us that the old debates are ...

The article explains how the coexistence of GloBE and GILTI leads to different tax outcomes for similarly structured multinational groups. Non-US companies face higher top-up taxes due to ...

Federal agencies and security and intelligence specialists have been ringing the bell, warning that foreign adversaries, including Iran, are seeking to exploit vulnerabilities in U.S. critical ...

ENR Deputy Editor Aileen Cho caught up with HNTB’s Diane Gutierrez-Scaccetti at the Transportation Research Board conference to talk about transportation trends, mentoring and her legacy of leadership ...

Jonathan Samet, Colorado School of Public Health, Aurora, Colorado. Ross C. Brownson ([email protected]), Washington University in St. Louis, St. Louis, Missouri. The COVID-19 pandemic and other ...

From the Hitler Youth to “constitutional patriotism”, how Habermas became one of the most important German philosophers of the 20th century. By Thomas Meaney This piece was originally published on 26 ...

Bio-Path Holdings, Inc. operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States. Its drug delivery and antisense technology is the ...